chr5-112821916-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.1333C>T(p.Gln445*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln445*) in the APC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with familial adenomatous polyposis (PMID: 19793053). ClinVar contains an entry for this variant (Variation ID: 438865). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q445* pathogenic mutation (also known as c.1333C>T), located in coding exon 10 of the APC gene, results from a C to T substitution at nucleotide position 1333. This changes the amino acid from a glutamine to a stop codon within coding exon 10. This mutation (designated p.Gln445X, c.1335C>T) was identified in one of 107 patients with FAP-like phenotype, with approximately 100 adenomas being noted throughout this individual's colon at age 37 (Filipe B et al. Clin. Genet. 2009 Sep;76:242-55). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at